Literature DB >> 2648719

CA 50 and CA 19-9 in serum as tumor markers for pancreatic cancer: a review of the literature.

A Andrén-Sandberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2648719

Source DB:  PubMed          Journal:  Acta Chir Scand Suppl        ISSN： 0301-1860


× No keyword cloud information.
  4 in total

1.  Increased serum CA 19-9 antibodies in Sjögren's syndrome.

Authors:  R Safadi; M Ligumsky; E Goldin; Y Ilan; Y S Haviv; S Nusair
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

Review 2.  Advances in biomarker research for pancreatic cancer.

Authors:  Kruttika Bhat; Fengfei Wang; Qingyong Ma; Qinyu Li; Sanku Mallik; Tze-Chen Hsieh; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.

Authors:  Yoshimi Haga; Koji Ueda
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

Review 4.  Molecular Targeted Intervention for Pancreatic Cancer.

Authors:  Altaf Mohammed; Naveena B Janakiram; Shubham Pant; Chinthalapally V Rao
Journal:  Cancers (Basel)       Date:  2015-08-10       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.